The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles
- 28 February 2005
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 48 (1) , 57-73
- https://doi.org/10.1016/j.brainresrev.2004.08.004
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Functional changes induced by neonatal cerebral 6-hydroxydopamine treatment: effects of dose levels on behavioral parametersBehavioural Brain Research, 1997
- Effects of neonatal dopamine depletion on sensory inhibition in the ratPharmacology Biochemistry and Behavior, 1996
- Active and passive avoidance learning in rats neonatally treated with intraventricular 6-hydroxydopamineBehavioural Brain Research, 1996
- Model for reduced brain dopamine in Lesch‐Nyhan syndrome and the mentally retarded: Neurobiology of neonatal‐6‐hydroxydopamine‐lesioned ratsMental Retardation and Developmental Disabilities Research Reviews, 1995
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801Life Sciences, 1989
- Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213Life Sciences, 1988
- Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in ratsLife Sciences, 1987
- Amphetamine reverses learning deficits in 6-hydroxydopamine-treated rat pupsDevelopmental Psychobiology, 1987
- Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987